Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Kevin M. Brown
Based on 34 articles published since 2009
(Why 34 articles?)
||||
Expertise Level
The expertise of Kevin M. Brown ranks in the
  • Top 1%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 34 articles on the topic.
Graphical view (beta)
Aliases Brown, Kevin M   ·   Brown, Kevin
Work Locations
Details
Most likely:    National Institutes of Health      
2019
  • Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA. · Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, 92697, USA. · Department of Food Science and Technology, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA. · Center for Bioinformatics and Computational Biology, Department of Computer Science, University of Maryland, College Park, MD, 20742, USA. · School of Computer Sciences and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. · Technion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, 31096, Israel. · Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA. · Department of Computer Science, College of Engineering and Computer Science, University of Central Florida, Orlando, FL, 32816, USA. · BioLegend, San Diego, CA, 92121, USA. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD, 20892, USA. · Departments of Dermatology and Oncology, Rambam Health Care Campus, Technion Faculty of Medicine, Haifa, 31096, Israel. · Department of Pathology, Yale University, New Haven, CT, USA. · Ludwig Institute for Cancer Research, Nuffield Department of Medicine, Old Road Campus, Unviversity of Oxford, Headington, Oxford, OX3 7DQ, UK. · Department of Dermatology, University Hospital of Zurich and University of Zurich, 8091, Zurich, Switzerland. · Cancer Data Science Lab, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. · Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA. · Technion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, 31096, Israel. · Pubmed 30940817
2018
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, United Kingdom. · Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, 4006, Australia. · Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Pubmed 30333196
  • Integrated Cancer Genomics Division, Translational Genomics Research Institute (TGen), Phoenix, Arizona, United States of America. · Department of Biomedical Informatics, Arizona State University, Phoenix, Arizona, United States of America. · Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, United States of America. · Department of Dermatology, Mayo Clinic, Scottsdale, Arizona, United States of America. · School of Life Sciences, Arizona State University, Phoenix, Arizona, United States of America. · Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, Australia. · Veterinary Genetics Laboratory, University of California Davis, Davis, California, United States of America. · Laboratory of Cancer and Developmental Cell Biology, Van Andel Research Institute (VARI), Grand Rapids, Michigan, United States of America. · Spectrum Health, Grand Rapids, Michigan, United States of America. · Program in Canine Genetics and Genomics, Van Andel Research Institute (VARI), Grand Rapids, Michigan, United States of America. · Neurogenomics Division, Translational Genomics Research Institute (TGen), Phoenix, Arizona, United States of America. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America. · Flint Animal Cancer Center, Colorado State University, Fort Collins, Colorado, United States of America. · The Veterinary Cancer Center, Norwalk, Connecticut, United States of America. · Innogenics Inc., Harvard, Massachusetts, United States of America. · Comparative Medicine Institute, North Carolina State University, Raleigh, NC, United States of America. · Pubmed 30188888
  • Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. · Department of Mathematics and Statistics, Laval University, Quebec, Canada. · Department of Dermatology, University of L'Aquila, L'Aquila, Italy. · Department of Dermatology, Maurizio Bufalini Hospital, Cesena, Italy. · Department of Internal Medicine and Medical Specialties, University of Genoa and Genetics of Rare Cancers, Ospedale Policlinico San Martino, Genoa, Italy. · Institute of Dermatology, Catholic University, Rome, Italy. · Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain and Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology and Molecular Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Cancer Genomics Program, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece. · Department of Epidemiology and Biostatistics, Imperial College London, London, UK. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, UK. · Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Sydney School of Public Health, and Melanoma Institute Australia, The University of Sydney, Sydney, Australia. · 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Department of Dermatology, Instituto Valenciano de Oncología, València, Spain. · Pubmed 30060076
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: · Pubmed 29245078
  • Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA. · Technion Integrated Cancer Center, Technion Israel Institute of Technology, Haifa, Israel. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, National Cancer Institute, Bethesda, Maryland, USA. · Department of Internal Medicine, Section of Medical Oncology, Yale University, New Haven, Connecticut, USA. · Cancer Research Center, Shantou University Medical College, Shantou, Guangdong, China. · Department of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · Pubmed 29227283
2017
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, the Netherlands. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · CNRS UMR 9187, INSERM U1196, Institut Curie, PSL Research University and Université Paris Sud, Université Paris Saclay, Orsay, France. · Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. · Translational Genomics Research Institute, Phoenix, Arizona, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Pubmed 28759004
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, The Netherlands. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA. · Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire 03756, USA. · Protein Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21701, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York City, New York 10065, USA. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA. · Translational Medicine and Human Genetics, Department of Medicine and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. · Pubmed 28447668
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. · Radboud Institute of Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands. · The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Radboud Institute of Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. · Pubmed 28108517
2016
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. · Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Qld, Australia. · Pubmed 26833684
  • Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD 20892, USA. · Department of Dermatology, University of Zürich, University of Zürich Hospital, Zürich 8091, Switzerland. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia. · Departments of Dermatology and Pathology, Yale University School of Medicine, New Haven, CT 06520, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Electronic address: · Pubmed 27210757
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. · Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands. · Strangeways Research Laboratory, Departments of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2, Worts Causeway, Cambridge, CB1 8RN, UK. · Strangeways Research Laboratory, Departments of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2, Worts Causeway, Cambridge, CB1 8RN, UK. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Pubmed 26433962
2015
  • Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. · Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Canada. Department of Oncology, McGill University, Montréal, Canada. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland. · Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · Departments of Dermatology and Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. · Pubmed 26603897
  • Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-946, Genetic Variation and Human Diseases Unit, Paris, France. · Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Western Australia, Australia. · Departments of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580, Heidelberg Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · Department of Pathology, Molecular Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel. · Oncogenetics Unit, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Laboratory of Genetics of Rare Cancers, Istituto di ricovero e cura a carattere scientifico Azienda Ospedaliera Universitaria (IRCCS AOU) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Université Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Institut National de la Santé et de la Recherche Médicale (INSERM U1153), Institut National de la Recherche Agronomique (INRA U1125), Conservatoire National des Arts et Métiers, Communauté d'Université Sorbonne Paris Cité, F-93017 Bobigny, France. · Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland, USA. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Surgery, Clinical Sciences, Lund University, Lund, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Medical Genetics, University of Glasgow, Glasgow, UK. · McGill University and Genome Quebec Innovation Centre, Montreal, Canada. · Department of Public Health, University of Glasgow, Glasgow UK. · Centre for Cancer Research, University of Sydney at Westmead, Millennium Institute for Medical Research and Melanoma Institute Australia, Sydney, Australia. · Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Oncology/Pathology, Clinical Sciences, Lund University, Lund; Sweden. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Melanoma Unit, Dermatology Department & Biochemistry and Molecular Genetics Departments, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Dermatology, The Warren Alpert Medical School of Brown University, Rhode Island, USA. · Inflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Gastroenterology and Hepatology, Royal Brisbane & Women's Hospital, Brisbane, Australia. · University of Queensland School of Medicine, Herston Campus, Brisbane, Australia. · Department of Clinical Genetics, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Ophthalmology, Flinders University, Adelaide, Australia. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Consortium Translational Cancer Research (DKTK), Heidelberg, Germany. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Oncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA. · Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA. · Department of Dermatology, Fachklinik Hornheide, Institute for Tumors of the Skin at the University of Münster, Münster, Germany. · Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA. · Pubmed 26237428
  • Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. Electronic address: · Massachusetts General Hospital, Harvard Medical School, Cambridge, MA 02114, USA. · Department of Dermatology, University Hospital of Zürich and University of Zürich, 8091 Zürich, Switzerland. · Departments of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. · Melanoma Research Center, Wistar Institute, Philadelphia, PA 19104, USA. · Weizmann Institute, Rehovot 76100, Israel. · QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. · Department of Dermatology, Yale School of Medicine, New Haven, CT 06520, USA. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. Electronic address: · Pubmed 26027934
  • Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland. · Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · Department of Dermatology, Yale University, School of Medicine, New Haven, Connecticut. Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Department of Dermatology, Yale University, School of Medicine, New Haven, Connecticut. · Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California. · Pubmed 25712345
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
2014
  • Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China. · Department of Community and Family Medicine, Center for Genomic Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03755, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. · Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia, Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia. · Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead, New South Wales 2145, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria 3053, Australia. · Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland 4004, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, · Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA · Pubmed 24980573
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · National Cancer Institute, Bethesda, Maryland, United States of America. · QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Translational Genomics Research Institute, Phoenix, Arizona, United States of America. · National Cancer Institute, Bethesda, Maryland, United States of America; Translational Genomics Research Institute, Phoenix, Arizona, United States of America. · Pubmed 24949998
  • Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK. · Section of Epidemiology and Biostatistics, Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Molecular Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Genetic Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Statistical Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK. · Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD, USA. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Leiden University Medical Centre, Leiden, The Netherlands. · Pubmed 24686849
2012
  • Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, DHHS, MD, USA. · Pubmed 22225770
Probable:    Radboud University      
2017
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. · Radboud Institute of Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands. · The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Radboud Institute of Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. · Pubmed 28108517
Probable:    Translational Genomics Research Institute      
2014
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · National Cancer Institute, Bethesda, Maryland, United States of America. · QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Translational Genomics Research Institute, Phoenix, Arizona, United States of America. · National Cancer Institute, Bethesda, Maryland, United States of America; Translational Genomics Research Institute, Phoenix, Arizona, United States of America. · Pubmed 24949998
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 34 total) written by Kevin M. Brown about Melanoma:

  • Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 2019
  • Cell-type-specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes. 2018
  • Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis. 2018
  • Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma. 2018
  • Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor. 2018
  • SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth. 2018
  • A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF. 2017
  • Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. 2017
  • (no title) 2017
  • The genomic landscape of cutaneous melanoma. 2016
Show List of Full Article Records
Google Searches

Learn more about Kevin M. Brown using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
National Institutes of Health
Radboud University
Translational Genomics Research Institute
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
National Institutes of Health
2019
  • Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA. · Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA, 92697, USA. · Department of Food Science and Technology, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA. · Center for Bioinformatics and Computational Biology, Department of Computer Science, University of Maryland, College Park, MD, 20742, USA. · School of Computer Sciences and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. · Technion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, 31096, Israel. · Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA. · Department of Computer Science, College of Engineering and Computer Science, University of Central Florida, Orlando, FL, 32816, USA. · BioLegend, San Diego, CA, 92121, USA. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD, 20892, USA. · Departments of Dermatology and Oncology, Rambam Health Care Campus, Technion Faculty of Medicine, Haifa, 31096, Israel. · Department of Pathology, Yale University, New Haven, CT, USA. · Ludwig Institute for Cancer Research, Nuffield Department of Medicine, Old Road Campus, Unviversity of Oxford, Headington, Oxford, OX3 7DQ, UK. · Department of Dermatology, University Hospital of Zurich and University of Zurich, 8091, Zurich, Switzerland. · Cancer Data Science Lab, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. · Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA. · Technion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, 31096, Israel. · Pubmed 30940817
2018
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, United Kingdom. · Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, 4006, Australia. · Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Pubmed 30333196
  • Integrated Cancer Genomics Division, Translational Genomics Research Institute (TGen), Phoenix, Arizona, United States of America. · Department of Biomedical Informatics, Arizona State University, Phoenix, Arizona, United States of America. · Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, United States of America. · Department of Dermatology, Mayo Clinic, Scottsdale, Arizona, United States of America. · School of Life Sciences, Arizona State University, Phoenix, Arizona, United States of America. · Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, Australia. · Veterinary Genetics Laboratory, University of California Davis, Davis, California, United States of America. · Laboratory of Cancer and Developmental Cell Biology, Van Andel Research Institute (VARI), Grand Rapids, Michigan, United States of America. · Spectrum Health, Grand Rapids, Michigan, United States of America. · Program in Canine Genetics and Genomics, Van Andel Research Institute (VARI), Grand Rapids, Michigan, United States of America. · Neurogenomics Division, Translational Genomics Research Institute (TGen), Phoenix, Arizona, United States of America. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America. · Flint Animal Cancer Center, Colorado State University, Fort Collins, Colorado, United States of America. · The Veterinary Cancer Center, Norwalk, Connecticut, United States of America. · Innogenics Inc., Harvard, Massachusetts, United States of America. · Comparative Medicine Institute, North Carolina State University, Raleigh, NC, United States of America. · Pubmed 30188888
  • Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. · Department of Mathematics and Statistics, Laval University, Quebec, Canada. · Department of Dermatology, University of L'Aquila, L'Aquila, Italy. · Department of Dermatology, Maurizio Bufalini Hospital, Cesena, Italy. · Department of Internal Medicine and Medical Specialties, University of Genoa and Genetics of Rare Cancers, Ospedale Policlinico San Martino, Genoa, Italy. · Institute of Dermatology, Catholic University, Rome, Italy. · Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain and Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology and Molecular Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Cancer Genomics Program, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece. · Department of Epidemiology and Biostatistics, Imperial College London, London, UK. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, UK. · Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Sydney School of Public Health, and Melanoma Institute Australia, The University of Sydney, Sydney, Australia. · 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Department of Dermatology, Instituto Valenciano de Oncología, València, Spain. · Pubmed 30060076
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: · Pubmed 29245078
  • Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA. · Technion Integrated Cancer Center, Technion Israel Institute of Technology, Haifa, Israel. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, National Cancer Institute, Bethesda, Maryland, USA. · Department of Internal Medicine, Section of Medical Oncology, Yale University, New Haven, Connecticut, USA. · Cancer Research Center, Shantou University Medical College, Shantou, Guangdong, China. · Department of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · Pubmed 29227283
2017
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, the Netherlands. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · CNRS UMR 9187, INSERM U1196, Institut Curie, PSL Research University and Université Paris Sud, Université Paris Saclay, Orsay, France. · Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. · Translational Genomics Research Institute, Phoenix, Arizona, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Pubmed 28759004
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, The Netherlands. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. · Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA. · Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire 03756, USA. · Protein Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21701, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York City, New York 10065, USA. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA. · Translational Medicine and Human Genetics, Department of Medicine and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. · Pubmed 28447668
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. · Radboud Institute of Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands. · The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Radboud Institute of Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. · Pubmed 28108517
2016
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. · Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Qld, Australia. · Pubmed 26833684
  • Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD 20892, USA. · Department of Dermatology, University of Zürich, University of Zürich Hospital, Zürich 8091, Switzerland. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia. · Departments of Dermatology and Pathology, Yale University School of Medicine, New Haven, CT 06520, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Electronic address: · Pubmed 27210757
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. · Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands. · Strangeways Research Laboratory, Departments of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2, Worts Causeway, Cambridge, CB1 8RN, UK. · Strangeways Research Laboratory, Departments of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2, Worts Causeway, Cambridge, CB1 8RN, UK. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Pubmed 26433962
2015
  • Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. · Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Canada. Department of Oncology, McGill University, Montréal, Canada. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland. · Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · Departments of Dermatology and Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. · Pubmed 26603897
  • Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-946, Genetic Variation and Human Diseases Unit, Paris, France. · Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Western Australia, Australia. · Departments of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580, Heidelberg Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · Department of Pathology, Molecular Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel. · Oncogenetics Unit, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Laboratory of Genetics of Rare Cancers, Istituto di ricovero e cura a carattere scientifico Azienda Ospedaliera Universitaria (IRCCS AOU) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Université Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Institut National de la Santé et de la Recherche Médicale (INSERM U1153), Institut National de la Recherche Agronomique (INRA U1125), Conservatoire National des Arts et Métiers, Communauté d'Université Sorbonne Paris Cité, F-93017 Bobigny, France. · Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland, USA. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Surgery, Clinical Sciences, Lund University, Lund, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Medical Genetics, University of Glasgow, Glasgow, UK. · McGill University and Genome Quebec Innovation Centre, Montreal, Canada. · Department of Public Health, University of Glasgow, Glasgow UK. · Centre for Cancer Research, University of Sydney at Westmead, Millennium Institute for Medical Research and Melanoma Institute Australia, Sydney, Australia. · Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Oncology/Pathology, Clinical Sciences, Lund University, Lund; Sweden. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Melanoma Unit, Dermatology Department & Biochemistry and Molecular Genetics Departments, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Dermatology, The Warren Alpert Medical School of Brown University, Rhode Island, USA. · Inflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Gastroenterology and Hepatology, Royal Brisbane & Women's Hospital, Brisbane, Australia. · University of Queensland School of Medicine, Herston Campus, Brisbane, Australia. · Department of Clinical Genetics, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Ophthalmology, Flinders University, Adelaide, Australia. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Consortium Translational Cancer Research (DKTK), Heidelberg, Germany. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Oncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA. · Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA. · Department of Dermatology, Fachklinik Hornheide, Institute for Tumors of the Skin at the University of Münster, Münster, Germany. · Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA. · Pubmed 26237428
  • Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. Electronic address: · Massachusetts General Hospital, Harvard Medical School, Cambridge, MA 02114, USA. · Department of Dermatology, University Hospital of Zürich and University of Zürich, 8091 Zürich, Switzerland. · Departments of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. · Melanoma Research Center, Wistar Institute, Philadelphia, PA 19104, USA. · Weizmann Institute, Rehovot 76100, Israel. · QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. · Department of Dermatology, Yale School of Medicine, New Haven, CT 06520, USA. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. Electronic address: · Pubmed 26027934
  • Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland. · Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · Department of Dermatology, Yale University, School of Medicine, New Haven, Connecticut. Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Department of Dermatology, Yale University, School of Medicine, New Haven, Connecticut. · Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California. · Pubmed 25712345
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
2014
  • Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China. · Department of Community and Family Medicine, Center for Genomic Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03755, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. · Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia, Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia. · Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead, New South Wales 2145, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria 3053, Australia. · Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland 4004, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, · Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA · Pubmed 24980573
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · National Cancer Institute, Bethesda, Maryland, United States of America. · QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Translational Genomics Research Institute, Phoenix, Arizona, United States of America. · National Cancer Institute, Bethesda, Maryland, United States of America; Translational Genomics Research Institute, Phoenix, Arizona, United States of America. · Pubmed 24949998
  • Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK. · Section of Epidemiology and Biostatistics, Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Molecular Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Genetic Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Statistical Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK. · Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD, USA. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Leiden University Medical Centre, Leiden, The Netherlands. · Pubmed 24686849
2012
  • Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, DHHS, MD, USA. · Pubmed 22225770
Radboud University
2017
  • Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. · Radboud Institute of Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands. · The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Radboud Institute of Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. · Pubmed 28108517
Translational Genomics Research Institute
2014
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · National Cancer Institute, Bethesda, Maryland, United States of America. · QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Translational Genomics Research Institute, Phoenix, Arizona, United States of America. · National Cancer Institute, Bethesda, Maryland, United States of America; Translational Genomics Research Institute, Phoenix, Arizona, United States of America. · Pubmed 24949998
20 Other Locations Show
Yearly article counts 15336423511
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.